Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Net Equity Issued and Repurchased (2016 - 2025)

Historic Net Equity Issued and Repurchased for Avricore Health (AVCRF) over the last 11 years, with Q3 2025 value amounting to -$234963.1.

  • Avricore Health's Net Equity Issued and Repurchased fell 24251.65% to -$234963.1 in Q3 2025 from the same period last year, while for Sep 2025 it was $515621.9, marking a year-over-year decrease of 1.75%. This contributed to the annual value of $2.1 million for FY2017, which is 55005.33% up from last year.
  • Avricore Health's Net Equity Issued and Repurchased amounted to -$234963.1 in Q3 2025, which was down 24251.65% from -$299160.7 recorded in Q2 2025.
  • Over the past 5 years, Avricore Health's Net Equity Issued and Repurchased peaked at $2.0 million during Q1 2021, and registered a low of -$441164.3 during Q3 2022.
  • For the 5-year period, Avricore Health's Net Equity Issued and Repurchased averaged around $244500.7, with its median value being -$30065.5 (2023).
  • Per our database at Business Quant, Avricore Health's Net Equity Issued and Repurchased soared by 52229.64% in 2021 and then crashed by 133916.8% in 2025.
  • Over the past 5 years, Avricore Health's Net Equity Issued and Repurchased (Quarter) stood at -$52512.0 in 2021, then crashed by 740.12% to -$441164.3 in 2022, then skyrocketed by 85.99% to -$61792.9 in 2023, then skyrocketed by 366.81% to $164867.4 in 2024, then crashed by 242.52% to -$234963.1 in 2025.
  • Its last three reported values are -$234963.1 in Q3 2025, -$299160.7 for Q2 2025, and $884878.3 during Q1 2025.